

CLASSIFICATION: DOPAMINE D2 AGONIST (ERGOLINE)
ACTIVE SUBSTANCE: CABERGOLINE
FORM: 8 TABLETS x 0.5 MG
ACTIVE HALF-LIFE: ~63–69 HOURS
DOSAGE: MEN 0.25 MG/WEEK
ACNE: LOW / NOT TYPICAL
WATER RETENTION: NONE EXPECTED
HIGH BLOOD PRESSURE (HBP): NOT TYPICAL
HEPATOTOXICITY: NONE EXPECTED
AROMATIZATION: NONE
MANUFACTURER: PFIZER
Dostinex contains cabergoline, a long-acting dopamine D2 receptor agonist used under medical supervision to manage disorders associated with elevated prolactin. In performance contexts, athletes sometimes encounter prolactin-related symptoms—such as low libido, mood changes, or nipple discharge—particularly when using 19-nor compounds. While lifestyle factors and cycle design are the first lines of defense, clinically managed cabergoline may be prescribed by a physician to normalize prolactin and relieve associated symptoms.
Important: Dostinex is a prescription medication. Use it only under the guidance of a licensed healthcare professional. It is not a substitute for a well-planned protocol or post-cycle strategy.
Cabergoline selectively stimulates dopamine D2 receptors in the pituitary to reduce prolactin secretion. When prolactin normalizes, users commonly report a steadier mood, better sexual wellbeing, and fewer prolactin-linked side effects. Because cabergoline is long-acting, its effect persists between scheduled doses, supporting consistent control without day-to-day fluctuations.
In situations where estradiol is also elevated, managing estrogen remains essential. Consider a physician-guided aromatase inhibitor alongside lifestyle changes. For reference, see our in-stock options like Dragon Pharma Arimidex (Anastrozole) and Dragon Pharma Letrozole.
Form & strength: 0.5 mg tablets (8 per pack).
Label-based initiation: Many clinicians start at 0.25 mg twice weekly and reassess labs after several weeks, adjusting in small steps to the lowest effective dose. Your doctor will set the schedule that fits your case.
Timing: Because cabergoline has a multi-day active half-life, twice-weekly dosing is common in clinical practice. Taking tablets with food may improve GI tolerance. Do not exceed your prescriber's instructions.
Avoid "self-correction": If you overshoot and drive prolactin too low, you may see the opposite problem (e.g., low libido, fatigue). Always titrate under medical supervision and confirm with labs.
Authoritative reference on indications, dosing principles, and safety can be found in the FDA Prescribing Information for Dostinex.
Cabergoline is generally well tolerated, but it can cause nausea, dizziness/orthostatic hypotension (lightheadedness when standing), headache, and occasionally sleep disturbances. Rarely, dopamine agonists are associated with impulse-control issues or mood changes. Discontinue and seek medical help if you experience chest pain, shortness of breath, swelling, new heart murmur, or severe mood changes.
Heart & fibrosis considerations: Long-term use of certain ergot-derived dopamine agonists has been linked—mostly at higher cumulative doses—to valvular and extrapulmonary fibrotic effects. For patients on extended therapy, clinicians often evaluate cardiovascular status and may order baseline and periodic echocardiography. Your provider will decide what monitoring is appropriate for you.
Interactions & conflicts: Avoid combining with dopamine antagonists (e.g., some antipsychotics) that counteract cabergoline's effect. Alcohol, dehydration, or stimulants may exacerbate dizziness. Always disclose all medications and supplements to your clinician.
Cabergoline is not a replacement for estrogen management or a comprehensive recovery plan. If your protocol also requires PCT, physician-guided SERMs are standard options. Explore our related inventory to plan your stack responsibly:
Using a targeted AI during aromatizable cycles, followed by smart SERM-based recovery, can address the root causes of estrogen/prolactin imbalance rather than "chasing symptoms." Cabergoline, when indicated by labs, complements (not replaces) those fundamentals.
This listing is for genuine Pfizer Dostinex 0.5 mg tablets (8 count). We store inventory properly and ship discreetly. As always, use under supervision and in accordance with local laws.
Disclaimer: The content above is informational and not medical advice. Always consult a licensed healthcare professional before using prescription medication.
Cabergoline is a dopamine D2 agonist that reduces prolactin release from the pituitary. When prescribed for hyperprolactinemia, normalizing prolactin may improve energy, libido, and other prolactin-linked symptoms.
Clinicians often start at 0.25 mg twice weekly and titrate slowly to the lowest effective dose, reassessing labs after several weeks. Use only as prescribed by your doctor.
Cabergoline has a multi-day elimination half-life (about 63–69 hours in healthy subjects), so twice-weekly schedules are common in clinical use. Your clinician sets the exact plan.
Possible effects include nausea, dizziness (especially on standing), headache, and sleep changes. Long-term therapy may require clinician-directed heart monitoring due to rare valvular/fibrotic risks. Seek care for chest pain, swelling, breathlessness, or severe mood changes.
Often, yes—when supervised by a clinician. Estrogen management (e.g., with an aromatase inhibitor) and SERM-based PCT address root causes. See related options like Dragon Pharma Arimidex, Letrozole, Clomid, Enclomiphene, and HCG.
Please log in to write DOSTINEX 0.5 MG (8 TABLETS) review.
CLASSIFICATION: RECOMBINANT HUMAN GROWTH HORMONE (rHGH)
ACTIVE SUBSTANCE: SOMATROPIN
FORM: 1 PRE-FILLED PEN x 36 IU (12 MG)
ACTIVE HALF-LIFE: ~3.5 HOURS (SUBQ)
DOSAGE: 1–4 IU/DAY FOR ANTI-AGING; 4–8 IU/DAY FOR FAT LOSS OR PERFORMANCE
WATER RETENTION: POSSIBLE (DOSE DEPENDENT)
HEPATOTOXICITY: NONE
AROMATIZATION: NO
MANUFACTURER: PFIZER
CLASSIFICATION: STEROIDAL AROMATASE INHIBITOR (AI)
ACTIVE SUBSTANCE: EXEMESTANE
FORM: 30 TABLETS x 25 MG
ACTIVE HALF-LIFE: ~24 HOURS
DOSAGE: MEN 25 MG ONCE DAILY
ACNE: POSSIBLE
WATER RETENTION: NO
HIGH BLOOD PRESSURE (HBP): NOT TYPICAL
HEPATOTOXICITY: RARE
AROMATIZATION: NONE
MANUFACTURER: PFIZER
CLASSIFICATION: PDE5 INHIBITOR (ERECTILE DYSFUNCTION)
ACTIVE SUBSTANCE: SILDENAFIL CITRATE
FORM: 4 TABLETS x 100 MG
ACTIVE HALF-LIFE: ~4 HOURS
DOSAGE: MEN 50-100 MG/DAY
ACNE: NOT APPLICABLE
WATER RETENTION: NONE
HIGH BLOOD PRESSURE (HBP): MAY LOWER BP
HEPATOTOXICITY: NOT TYPICAL
AROMATIZATION: NONE
MANUFACTURER: PFIZER